267 related articles for article (PubMed ID: 32205288)
1. Tenofovir prophylaxis for preventing mother-to-child hepatitis B virus transmission in China: A cost-effectiveness analysis.
Yin J; Liang P; Chen G; Wang F; Cui F; Liang X; Zhuang G
Int J Infect Dis; 2020 Jun; 95():118-124. PubMed ID: 32205288
[TBL] [Abstract][Full Text] [Related]
2. Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China.
Cui F; Woodring J; Chan P; Xu F
Int J Epidemiol; 2018 Oct; 47(5):1529-1537. PubMed ID: 29757383
[TBL] [Abstract][Full Text] [Related]
3. Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa.
Mokaya J; Burn EAO; Tamandjou CR; Goedhals D; Barnes EJ; Andersson M; Pinedo-Villanueva R; Matthews PC
BMC Public Health; 2019 Jun; 19(1):829. PubMed ID: 31242901
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of testing hepatitis B-positive pregnant women for hepatitis B e antigen or viral load.
Fan L; Owusu-Edusei K; Schillie SF; Murphy TV
Obstet Gynecol; 2014 May; 123(5):929-937. PubMed ID: 24785842
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of tenofovir prophylaxis during pregnancy for the elimination of mother-to-child transmission of the hepatitis B virus: real-world analysis from Thailand.
Janekrongtham C; Punsuwan N; Thitichai P; Lertpiriyasuwat C; Pan-Ngum W; Poovorawan K; Jantarapakde J; Tangkijvanich P
BMJ Open; 2023 Jul; 13(7):e067275. PubMed ID: 37474179
[TBL] [Abstract][Full Text] [Related]
6. The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: A large prospective cohort study in China.
Lu Y; Zhu FC; Liu JX; Zhai XJ; Chang ZJ; Yan L; Wei KP; Zhang X; Zhuang H; Li J
Vaccine; 2017 Dec; 35(48 Pt B):6627-6633. PubMed ID: 29079104
[TBL] [Abstract][Full Text] [Related]
7. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection.
Fan L; Owusu-Edusei K; Schillie SF; Murphy TV
Hepatology; 2016 May; 63(5):1471-80. PubMed ID: 26509655
[TBL] [Abstract][Full Text] [Related]
9. Costs of integrating hepatitis B screening and antiviral prophylaxis into routine antenatal care in Burkina Faso: Treat all versus targeted strategies.
Gosset A; Drabo S; Carrieri P; Tiendrebeogo ASE; Vincent JP; Tanaka Y; Sombié R; Tall H; Kania D; Boyer S; Shimakawa Y
Int J Gynaecol Obstet; 2024 Jul; 166(1):44-61. PubMed ID: 38567863
[TBL] [Abstract][Full Text] [Related]
10. Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis.
Bierhoff M; Angkurawaranon C; Rijken MJ; Sriprawa K; Kobphan P; Nosten FN; van Vugt M; McGready R; Devine A
BMC Pregnancy Childbirth; 2021 Feb; 21(1):157. PubMed ID: 33618698
[TBL] [Abstract][Full Text] [Related]
11. Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus.
Lu Y; Song Y; Zhai X; Zhu F; Liu J; Chang Z; Li Y; Xiao Y; Li L; Liu M; Liu J; Duan Z; Zou H; Zhuang H; Wang J; Li J
Emerg Microbes Infect; 2021 Dec; 10(1):555-564. PubMed ID: 33682609
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV.
Wang J; Liu J; Qi C; Yan T; Cao F; Jin L; He Y; Yang Y; Zhang S; Chen T; Zhao Y
Antivir Ther; 2015; 20(7):681-7. PubMed ID: 26215771
[TBL] [Abstract][Full Text] [Related]
13. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
Pan CQ; Duan Z; Dai E; Zhang S; Han G; Wang Y; Zhang H; Zou H; Zhu B; Zhao W; Jiang H;
N Engl J Med; 2016 Jun; 374(24):2324-34. PubMed ID: 27305192
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region.
Samadi Kochaksaraei G; Castillo E; Osman M; Simmonds K; Scott AN; Oshiomogho JI; Lee SS; Myers RP; Martin SR; Coffin CS
J Viral Hepat; 2016 Jan; 23(1):15-22. PubMed ID: 26192022
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with mother-to-child transmission of hepatitis B virus despite immunoprophylaxis.
Liu CP; Zeng YL; Zhou M; Chen LL; Hu R; Wang L; Tang H
Intern Med; 2015; 54(7):711-6. PubMed ID: 25832930
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of prophylactic lamivudine use in preventing vertical transmission of hepatitis B virus infection.
Hung HF; Chen HH
Pharmacoeconomics; 2011 Dec; 29(12):1063-73. PubMed ID: 22077578
[TBL] [Abstract][Full Text] [Related]
17. Management Algorithm for Interrupting Mother-to-Child Transmission of Hepatitis B Virus.
Hou J; Cui F; Ding Y; Dou X; Duan Z; Han G; Jia J; Mao Q; Li J; Li Z; Liu Z; Wei L; Xie Q; Yang X; Zhang H; Zhuang H
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):1929-1936.e1. PubMed ID: 30312789
[TBL] [Abstract][Full Text] [Related]
18. Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiative.
Evans AA; Cohen C; Huang P; Qian L; London WT; Block JM; Chen G
Vaccine; 2015 Jun; 33(26):3010-5. PubMed ID: 25698491
[TBL] [Abstract][Full Text] [Related]
19. [Economic evaluation on strategy for preventing mother-to-child transmission of hepatitis B in Zhejiang Province].
Zeng YB; Luo ML; He HQ; Deng X; Xie SY; Fang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):706-712. PubMed ID: 31288342
[No Abstract] [Full Text] [Related]
20. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
Jourdain G; Ngo-Giang-Huong N; Harrison L; Decker L; Khamduang W; Tierney C; Salvadori N; Cressey TR; Sirirungsi W; Achalapong J; Yuthavisuthi P; Kanjanavikai P; Na Ayudhaya OP; Siriwachirachai T; Prommas S; Sabsanong P; Limtrakul A; Varadisai S; Putiyanun C; Suriyachai P; Liampongsabuddhi P; Sangsawang S; Matanasarawut W; Buranabanjasatean S; Puernngooluerm P; Bowonwatanuwong C; Puthanakit T; Klinbuayaem V; Thongsawat S; Thanprasertsuk S; Siberry GK; Watts DH; Chakhtoura N; Murphy TV; Nelson NP; Chung RT; Pol S; Chotivanich N
N Engl J Med; 2018 Mar; 378(10):911-923. PubMed ID: 29514030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
